Becton Dickinson to Acquire Edwards Lifesciences’ Unit for $4.2 Billion in Cash

Becton Dickinson agreed to acquire an Edwards Lifesciences unit for $4.2 billion in cash, putting the transaction near the top of its many M&A deals.